跳至主要内容
临床试验/JPRN-UMIN000004624
JPRN-UMIN000004624招募中未知

Prospective study about the improvement of therapeutic invasiveness by oral intake of branched-chain amino acid (BCAA) supplement in hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) - Prospective study about the improvement of therapeutic invasiveness by oral intake of BCAA supplement in HCC patients after TACE and RFA

Department of Gastroenterology, Kobe University Graduate School of Medicine0 个研究点目标入组 150 人开始时间: 2010年11月29日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Those who had refractory ascites, overt hepatic encephalopathy, uncontrolled esophageal varices, severe jaundice, Child's grade C and portal vein trunk thrombosis were excluded from the study. In addition, those who used intravenous albumin regularly were also excluded.

研究者

发起方
Department of Gastroenterology, Kobe University Graduate School of Medicine

相似试验